Northern Trust’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.23M | Sell |
725,187
-13,055
| -2% | -$56.5K | ﹤0.01% | 2915 |
|
|
2025
Q4 | $2.63M | Sell |
738,242
-34,770
| -4% | -$213K | ﹤0.01% | 2838 |
|
|
2025
Q3 | $6.88M | Sell |
773,012
-4,153
| -0.5% | -$42.1K | ﹤0.01% | 2319 |
|
|
2025
Q2 | $7.17M | Buy |
777,165
+42,434
| +6% | +$362K | ﹤0.01% | 2254 |
|
|
2025
Q1 | $6.3M | Buy |
734,731
+27,830
| +4% | +$263K | ﹤0.01% | 2294 |
|
|
2024
Q4 | $7.59M | Buy |
706,901
+10,938
| +2% | +$84.1K | ﹤0.01% | 2281 |
|
|
2024
Q3 | $3.95M | Buy |
695,963
+26,807
| +4% | +$155K | ﹤0.01% | 2615 |
|
|
2024
Q2 | $2.82M | Sell |
669,156
-49,599
| -7% | -$201K | ﹤0.01% | 2719 |
|
|
2024
Q1 | $3.66M | Sell |
718,755
-22,670
| -3% | -$128K | ﹤0.01% | 2656 |
|
|
2023
Q4 | $6.9M | Sell |
741,425
-9,942
| -1% | -$68.4K | ﹤0.01% | 2313 |
|
|
2023
Q3 | $4.92M | Buy |
751,367
+15,379
| +2% | +$122K | ﹤0.01% | 2459 |
|
|
2023
Q2 | $5.98M | Buy |
735,988
+8,980
| +1% | +$77K | ﹤0.01% | 2414 |
|
|
2023
Q1 | $6.23M | Sell |
727,008
-171
| -0% | -$1.71K | ﹤0.01% | 2321 |
|
|
2022
Q4 | $6.73M | Buy |
727,179
+12,069
| +2% | +$129K | ﹤0.01% | 2284 |
|
|
2022
Q3 | $7.38M | Buy |
715,110
+3,052
| +0.4% | +$32.2K | ﹤0.01% | 2200 |
|
|
2022
Q2 | $7.13M | Buy |
712,058
+22,986
| +3% | +$218K | ﹤0.01% | 2279 |
|
|
2022
Q1 | $8.48M | Sell |
689,072
-17,409
| -2% | -$214K | ﹤0.01% | 2251 |
|
|
2021
Q4 | $12.3M | Buy |
706,481
+23,625
| +3% | +$449K | ﹤0.01% | 2096 |
|
|
2021
Q3 | $12.3M | Sell |
682,856
-7,179
| -1% | -$143K | ﹤0.01% | 2132 |
|
|
2021
Q2 | $15.8M | Buy |
690,035
+36,539
| +6% | +$541K | ﹤0.01% | 2057 |
|
|
2021
Q1 | $9.77M | Sell |
653,496
-57
| -0% | -$623 | ﹤0.01% | 2305 |
|
|
2020
Q4 | $3.53M | Sell |
653,553
-11,197
| -2% | -$59K | ﹤0.01% | 2876 |
|
|
2020
Q3 | $3.02M | Sell |
664,750
-5,252
| -0.8% | -$22.6K | ﹤0.01% | 2836 |
|
|
2020
Q2 | $3.3M | Buy |
670,002
+51,645
| +8% | +$195K | ﹤0.01% | 2766 |
|
|
2020
Q1 | $1.95M | Buy |
618,357
+69,098
| +13% | +$241K | ﹤0.01% | 2875 |
|
|
2019
Q4 | $1.42M | Buy |
549,259
+35,524
| +7% | +$93.2K | ﹤0.01% | 3274 |
|
|
2019
Q3 | $1.62M | Buy |
513,735
+366,290
| +248% | +$1.06M | ﹤0.01% | 3214 |
|
|
2019
Q2 | $497K | Buy |
147,445
+36,073
| +32% | +$112K | ﹤0.01% | 3550 |
|
|
2019
Q1 | $339K | Sell |
111,372
-122
| -0.1% | -$291 | ﹤0.01% | 3636 |
|
|
2018
Q4 | $174K | Sell |
111,494
-485
| -0.4% | -$1.1K | ﹤0.01% | 3823 |
|
|
2018
Q3 | $305K | Hold |
111,979
| – | – | ﹤0.01% | 3758 |
|
|
2018
Q2 | $293K | Sell |
111,979
-337,782
| -75% | -$944K | ﹤0.01% | 3740 |
|
|
2018
Q1 | $1.24M | Buy |
449,761
+26,595
| +6% | +$75.1K | ﹤0.01% | 3311 |
|
|
2017
Q4 | $1.36M | Sell |
423,166
-4,180
| -1% | -$16.5K | ﹤0.01% | 3303 |
|
|
2017
Q3 | $1.77M | Sell |
427,346
-1,727
| -0.4% | -$7.68K | ﹤0.01% | 3247 |
|
|
2017
Q2 | $2.28M | Buy |
429,073
+59,069
| +16% | +$341K | ﹤0.01% | 3098 |
|
|
2017
Q1 | $2.12M | Buy |
370,004
+19,161
| +5% | +$99K | ﹤0.01% | 3053 |
|
|
2016
Q4 | $1.39M | Sell |
350,843
-10,245
| -3% | -$36.5K | ﹤0.01% | 3254 |
|
|
2016
Q3 | $1.31M | Buy |
361,088
+248,221
| +220% | +$1.05M | ﹤0.01% | 3266 |
|
|
2016
Q2 | $689K | Buy |
112,867
+58,307
| +107% | +$282K | ﹤0.01% | 3439 |
|
|
2016
Q1 | $267K | Buy |
54,560
+5,444
| +11% | +$23.9K | ﹤0.01% | 3635 |
|
|
2015
Q4 | $274K | Buy |
+49,116
| New | +$349K | ﹤0.01% | 3663 |
|
Other funds holding AVXL
VCM
SF
VPM